These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The significance of immunoglobulins in the treatment of patients with sepsis and septic shock. Bojić I; Begović V; Trnjak Z; Dokić M Vojnosanit Pregl; 1998; 55(2 Suppl):75-8. PubMed ID: 9623363 [TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy: the strategic approach to the treatment of patients with severe sepsis]. Pidhirnyĭ IaM Klin Khir; 2005 Jul; (7):32-7. PubMed ID: 16255220 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins and sepsis. Shankar-Hari M; Madsen MB; Turgeon AF Intensive Care Med; 2018 Nov; 44(11):1923-1925. PubMed ID: 29349688 [No Abstract] [Full Text] [Related]
7. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock. Neugebauer EA Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203 [No Abstract] [Full Text] [Related]
8. Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: a case report. Kyles DM; Baltimore J Am J Crit Care; 2005 Mar; 14(2):109-12. PubMed ID: 15728952 [No Abstract] [Full Text] [Related]
10. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247 [TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin for neonates. Green A MCN Am J Matern Child Nurs; 1991; 16(4):208-11. PubMed ID: 1943529 [No Abstract] [Full Text] [Related]
12. Outcome assessment--the pros and cons of TISS as the primary objective. Dellinger RP Eur J Surg Suppl; 1999; (584):49-50. PubMed ID: 10890233 [No Abstract] [Full Text] [Related]
13. Advances in the therapy for sepsis in children. Anderson MR; Blumer JL Pediatr Clin North Am; 1997 Feb; 44(1):179-205. PubMed ID: 9057790 [TBL] [Abstract][Full Text] [Related]
15. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Laupland KB; Kirkpatrick AW; Delaney A Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465 [TBL] [Abstract][Full Text] [Related]
16. Supplemental immune globulins in sepsis: a critical appraisal. Werdan K; Pilz G Clin Exp Immunol; 1996 May; 104 Suppl 1():83-90. PubMed ID: 8625550 [TBL] [Abstract][Full Text] [Related]
17. [Use of octagam and pentaglobin in the treatment of severe sepsis in the neonatal period]. Barinov AV; Ol'mezov VV Anesteziol Reanimatol; 1999; (3):59-60. PubMed ID: 10458040 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulins in neonatal sepsis: has the final word been said? Capasso L; Borrelli AC; Ferrara T; Coppola C; Cerullo J; Izzo F; Caiazza R; Lama S; Raimondi F Early Hum Dev; 2014 Sep; 90 Suppl 2():S47-9. PubMed ID: 25220128 [TBL] [Abstract][Full Text] [Related]
19. Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Hampson FG; Hancock SW; Primhak RA Arch Dis Child; 2006 Feb; 91(2):201. PubMed ID: 16428374 [No Abstract] [Full Text] [Related]